Buchumschlag

Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Serdar Turan, Cem Tugrul Gezmis, Nusret Can Cilesiz, Mehmet Uzut, Mustafa Satılmısoglu, Rifat Burak Ergul, Mustafa Bahadır Can Balcı
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	BJUI Compass
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
von: Alison Hiong, et al.
Veröffentlicht: (2025)

Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
von: Katherina Y. Chen, et al.
Veröffentlicht: (2026)

Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
von: Liam Mannion, et al.
Veröffentlicht: (2024)

Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
von: Shugo Yajima, et al.
Veröffentlicht: (2025)

Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
von: Sean Lim, et al.
Veröffentlicht: (2026)

Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
von: Jacob Hanna, et al.
Veröffentlicht: (2026)

Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
von: Rachel Weng, et al.
Veröffentlicht: (2025)

Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
von: Chase Peng Yun Ng, et al.
Veröffentlicht: (2025)

A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
von: John Lahoud, et al.
Veröffentlicht: (2024)

Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
von: Makito Miyake, et al.
Veröffentlicht: (2025)

Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
von: Amandeep Arora, et al.
Veröffentlicht: (2025)

Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
von: Yu Ishizuya, et al.
Veröffentlicht: (2026)

Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
von: Kylie Yen‐Yi Lim, et al.
Veröffentlicht: (2025)

Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
von: Kira Furlano, et al.
Veröffentlicht: (2024)

Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
von: Cameron E. Alexander, et al.
Veröffentlicht: (2024)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
von: Arjun Pon Avudaiappan, et al.
Veröffentlicht: (2024)

Patient experience of bladder cancer: A data linkage study
von: Snehadhar Shah, et al.
Veröffentlicht: (2024)

Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
von: Liwu Guo, et al.
Veröffentlicht: (2024)

Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
von: Hugo Klempfner, et al.
Veröffentlicht: (2024)

Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
von: Yin Zhou, et al.
Veröffentlicht: (2024)

Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
von: Rodolfo Hurle, et al.
Veröffentlicht: (2025)

The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
von: Kunal K. Sindhu, et al.
Veröffentlicht: (2024)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
von: Eric Margolis, et al.
Veröffentlicht: (2025)

Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
von: Mohammed Al‐Zubaidi, et al.
Veröffentlicht: (2024)

Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
von: Rebecca Martin, et al.
Veröffentlicht: (2025)

First validation of the Prostatype® P‐score in an Asian cohort: Improving risk stratification for prostate cancer
von: See‐Tong Pang, et al.
Veröffentlicht: (2025)

Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
von: Thomas Philip Cahill, et al.
Veröffentlicht: (2024)

Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
von: Alexander Hintze Hillers, et al.
Veröffentlicht: (2024)

Quantification of perineural invasion on prostate biopsy improves risk stratification in biopsy Grade Group 2–3 cancer
von: Yuki Teramoto, et al.
Veröffentlicht: (2026)

Preoperative pelvic floor muscle diameter as a predictor of postoperative urinary incontinence in robotic‐assisted laparoscopic total prostatectomy
von: Sho Hashimoto, et al.
Veröffentlicht: (2025)

Health utility value of overactive bladder in Japanese older adults
von: Takashi Yoshioka, et al.
Veröffentlicht: (2024)

Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
von: Joshua D. Cabral, et al.
Veröffentlicht: (2026)

Emerging tools for the early detection of prostate cancer
von: Muhammad Haider, et al.
Veröffentlicht: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
von: Sophia M. Abusamra, et al.
Veröffentlicht: (2025)

Thoughts on ‘Efficacy of RestoreX after prostatectomy: open‐label phase of an RCT’
von: Mustafa Ganijee, et al.
Veröffentlicht: (2024)

Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
von: Sezgin Yeni, et al.
Veröffentlicht: (2025)

Bibliometric analysis of focal therapy in prostate cancer research
von: Mohammed Shahait, et al.
Veröffentlicht: (2024)

Alcohol consumption among patients diagnosed with genitourinary cancers
von: Aidan Weitzner, et al.
Veröffentlicht: (2025)

Penile cancer in French Guiana: Epidemiology, histopathology and clinical aspects
von: Khalil Chalhoub, et al.
Veröffentlicht: (2025)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
von: Ailene E. Corona, et al.
Veröffentlicht: (2026)